150
Participants
Start Date
January 31, 2003
Primary Completion Date
December 31, 2008
Study Completion Date
June 30, 2009
Naltrexone
Naltrexone (50 mg/day) plus gabapentin placebo in divided doses for the first 6weeks. Naltrexone (50 mg/day) for rest of 16-weeks
Naltrexone plus Gabapentin
naltrexone (50 mg/day) for 16-weeks plus gabapentin (up to 1200 mg/day in divided doses) for the first 6 weeks
Inactive Placebo
Placebo
Medical University of South Carolina, Center for Drug and Alcohol Programs, Charleston
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Medical University of South Carolina
OTHER